Jørn Brynskov

Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Casper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen et al. · Gut · 2013 · 454 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's Disease

Jørn Brynskov, L Freund, Sten Nørby Rasmussen et al. · New England Journal of Medicine · 1989 · 376 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

Matthieu Allez, Konstantinos Κarmiris, Édouard Louis et al. · Journal of Crohn s and Colitis · 2010 · 337 citations · Full text

Medicine, Immunology, Pharmacology +15

Safety of Celecoxib in Patients With Ulcerative Colitis in Remission: A Randomized, Placebo-Controlled, Pilot Study

William J. Sandborn, William F. Stenson, Jørn Brynskov et al. · Clinical Gastroenterology and Hepatology · 2006 · 230 citations

Medicine, Pharmacology, Pharmacotherapy +10

Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease

Jørn Brynskov, Pia Foegh, Gitte Pedersen et al. · Gut · 2002 · 196 citations · Full text

Life Sciences, Immunology, Pathobiology +17